FIELD: chemistry.
SUBSTANCE: formula (I) compound has antibacterial activity and can be used as a medicinal agent. In formula 
, 
R1 is hydrogen, halogen, C1-4alkyl; R2 is selected from hydrogen, halogen, C1-4alkyl; R3 is selected from hydrogen, halogen, cyano, C1-4alkyl; W is -N(R6)-; X is a single bond; ring A is an unsaturated or partially saturated ring containing 5-6 atoms, one or two of which are independently selected from nitrogen and sulphur; or an unsaturated or partially saturated bicyclic ring containing 9-10 atoms, one, two or three of which are selected from nitrogen and sulphur; R4 and R5 are substitutes on a carbon atom and are independently selected from a halogen, nitro, cyano, hydroxy, amino, carboxy, carbamoyl, formyl, hydroxy iminomethyl, C1-4alkoxyminomethyl, C1-4alkyl, C1-4alkoxy, C1-4alkanoyl, C1-4alkoxy)carbamoyl, N-(C1-4alkyl)-N-(C1-4alkoxy)carbamoyl, C1-4alkylS(O)a, where a equals 0-2, C1-4alkoxycarbonyl, C1-4alkoxycarbonylamino, C1-4alkylsulphonylamino, (saturated or unsaturated carbocycle containing 3-7 atoms)-R10- or (saturated, partially saturated or unsaturated ring containing 5-6 atoms, one or two of which are selected from nitrogen, oxygen and sulphur)-R11-; where R4 and R5 can independently and optionally substituted at the carbon atom with one or more R12; R6 is hydrogen; n equals 1-4; where values of R4 can be identical or different; m equals 0-4; where values of R5 can be identical or different; R12 is selected from azido, halogen, cyano, hydroxy, amino, carboxy, C1-4alkyl, C2-4alkenyl, C2-4alkynyl, C1-4alkoxy, C1-4alkanoyl, N-(C1-4alkyl)amino, N,N-(C1-4alkyl)2amino, C1-4alkylS(O)a, where a equals 0-2, (saturated or unsaturated cabocycle containing 3-7 atoms)-R14- or (saturated, partially saturated or unsaturated ring containing 5 or 6 atoms, one or two of which are selected from nitrogen, oxygen and sulphur)-R15-; where R12 can independently and optionally be substituted at the carbon atom with one or more R9; R10, R11, R14 and R15 are independently selected from a single bond, -C(O)-, -N(R19)C(O)- or -C(O)N(R20)-; where R19 and R20 are independently selected from hydrogen or C1-4alkyl; R16 is selected from halogen, cyano, hydroxy, carboxy, methyl and methoxy. The invention also relates to a pharmaceutical composition, having antibacterial activity, containing the disclosed compound as an active ingredient, use of the disclosed compound to prepare a medicinal agent and a method of producing the compound of formula (I).
EFFECT: high activity of the compounds.
22 cl, 52 tbl, 721 ex
| Title | Year | Author | Number | 
|---|---|---|---|
| PYRIDINES SUBSTITUTED WITH HETEROARYL AND APPLICATION METHODS | 2017 | 
									
  | 
                RU2756743C2 | 
| PYRROLOTRIAZINE COMPOUNDS AS KINASE INHIBITORS | 2004 | 
									
  | 
                RU2373209C2 | 
| NEW PIPERIDINES AS CHEMOKINE (CCR) MODULATORS | 2005 | 
									
  | 
                RU2348616C2 | 
| PHARMACEUTICAL COMPOUNDS | 2019 | 
									
  | 
                RU2821941C2 | 
| 2-AZA-BICYCLO[3,1,0]HEXANE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | 2007 | 
									
  | 
                RU2460732C2 | 
| HETEROAROMATIC AND AROMATIC PIPERAZINYL AZETIDINYL AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | 2010 | 
									
  | 
                RU2558141C2 | 
| THIENOPYRIMIDNEDIONES, METHODS FOR THEIR PREPARING (VARIANTS) AND PHARMACEUTICAL COMPOSITION | 2002 | 
									
  | 
                RU2294937C9 | 
| AZASPIROALKANE DERIVATIVES METALLOPROTEASE INHIBITORS | 2004 | 
									
  | 
                RU2379303C2 | 
| THIENOPYRIMIDINDIONS AND THEIR APPLICATION IN AUTOIMMUNE DISEASE MODULATION | 2004 | 
									
  | 
                RU2332420C2 | 
| AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR | 2017 | 
									
  | 
                RU2764523C2 | 
Authors
Dates
2011-07-20—Published
2006-02-16—Filed